Oxidation-reduction reactions are fundamental to biological systems. Aerobic organisms continuously produce reactive oxygen species (ROS) as a consequence of normal metabolism, enzymatic reactions, immune activity, and environmental exposure. At controlled concentrations, reactive species are not necessarily harmful. Hydrogen peroxide and superoxide, for example, can participate in intracellular signaling and regulation of physiological processes. The modern concept of oxidative stress therefore recognizes that reactive species have both physiological and pathological functions.

Oxidative stress is broadly described as a disturbance in the balance between oxidants and antioxidants in favor of oxidants, with the potential to produce molecular and cellular damage. The concept has developed considerably since its introduction, and current redox biology emphasizes the importance of concentration, location, duration, and chemical identity of individual reactive species.

Reactive species are generated from several intracellular sources. Mitochondrial electron transport, NADPH oxidases, peroxisomal metabolism, xanthine oxidase, uncoupled nitric oxide synthase, and inflammatory cells can contribute to ROS and reactive nitrogen species production. Environmental factors such as cigarette smoke, ultraviolet radiation, air pollution, ionizing radiation, and certain chemicals can further increase oxidative burden.

Under physiological conditions, antioxidant systems continuously regulate reactive species. Important enzymatic defenses include superoxide dismutases (SODs), catalase (CAT), glutathione peroxidases (GPXs), peroxiredoxins, and glutathione-dependent enzymes. Non-enzymatic defenses include glutathione, uric acid, bilirubin, vitamin C, vitamin E, and numerous dietary compounds. The interaction between these systems establishes a dynamic redox environment that permits signaling while limiting molecular damage.

When reactive species production becomes excessive or antioxidant and repair mechanisms become insufficient, oxidative damage may occur. Lipid peroxidation can disrupt cellular membranes, protein oxidation can alter enzyme and receptor function, and oxidative DNA damage can contribute to mutations and genomic instability. These processes can subsequently activate inflammatory pathways, alter mitochondrial function, induce cell death, and contribute to chronic disease.

Oxidative stress has been associated with cardiovascular disease, diabetes, neurodegenerative disorders, cancer, pulmonary disease, kidney disease, and aging. Importantly, oxidative stress is often interconnected with inflammation, mitochondrial dysfunction, metabolic abnormalities, and impaired cellular repair.

The aim of this review is to summarize the molecular mechanisms through which oxidative stress contributes to human disease and to examine current and emerging therapeutic strategies designed to restore redox homeostasis.

2. Molecular Mechanisms of Oxidative Stress

Reactive Oxygen Species and Reactive Nitrogen Species

Reactive oxygen species include chemically diverse molecules with different biological properties. Major ROS include superoxide anion (O₂•⁻), hydrogen peroxide (H₂O₂), hydroxyl radical (•OH), and lipid-derived reactive species. Reactive nitrogen species include nitric oxide (NO•), peroxynitrite (ONOO⁻), and related nitrogen-containing oxidants.

Superoxide can be generated through one-electron reduction of molecular oxygen. Although relatively selective compared with hydroxyl radicals, superoxide can participate in important biological reactions and can be converted to hydrogen peroxide through spontaneous or SOD-catalyzed dismutation. Hydrogen peroxide is comparatively stable and can diffuse within cells, allowing it to function as an important redox-signaling molecule.

Hydroxyl radicals are extremely reactive and can damage nearby biological molecules. Their formation can be promoted by metal-catalyzed reactions involving hydrogen peroxide. Consequently, cellular systems tightly regulate transition metals and hydrogen peroxide concentrations.

The biological activity of reactive species is therefore highly dependent on their identity, concentration, subcellular location, and duration of exposure. Modern redox research increasingly recommends measuring specific reactive species rather than treating all ROS as a single biological entity.

Mitochondrial Generation of Reactive Species

Mitochondria are an important source and target of cellular ROS. During oxidative phosphorylation, electrons are transferred through the mitochondrial electron transport chain to generate ATP. A small fraction of electrons can react with molecular oxygen, producing superoxide.

Mitochondrial ROS can participate in physiological signaling, but excessive production may damage mitochondrial DNA, respiratory-chain proteins, membrane lipids, and mitochondrial membranes. Such damage can further impair electron transport and potentially increase ROS generation, creating a self-amplifying cycle.

Mitochondrial dysfunction is particularly important in aging and neurodegenerative diseases because neurons have high energy requirements and depend heavily on mitochondrial function. Oxidative damage to mitochondrial components can consequently influence neuronal survival and tissue function.

NADPH Oxidases

NADPH oxidases are specialized enzyme complexes that generate reactive oxygen species. Unlike mitochondrial ROS production, ROS generation by NADPH oxidases is often a regulated cellular process. These enzymes participate in immune defense, vascular signaling, cell migration, and other physiological processes.

However, excessive or inappropriate NADPH oxidase activation can contribute to vascular dysfunction, inflammation, fibrosis, and tissue injury. Consequently, NADPH oxidase-dependent ROS generation represents a potential disease-specific therapeutic target.

Oxidative Damage to Cellular Macromolecules

Oxidative stress can affect three major classes of cellular macromolecules: lipids, proteins, and nucleic acids.

Lipid oxidation

Polyunsaturated fatty acids in cellular membranes are particularly susceptible to oxidation. Lipid peroxidation generates reactive aldehydes and other secondary products that can modify proteins and DNA. Lipid oxidation can alter membrane permeability, receptor function, mitochondrial integrity, and cellular signaling.

Protein oxidation

ROS can oxidize amino acid side chains and modify protein structure and function. Cysteine and methionine residues are particularly important because their reversible oxidation can participate in redox signaling. More severe oxidation may result in irreversible protein dysfunction and degradation.

Recent work has emphasized oxidative post-translational modifications such as protein sulfenylation as important components of redox signaling and disease mechanisms.

DNA oxidation

Oxidative damage to DNA can produce modified bases, strand breaks, and genomic instability. One widely studied marker is 8-hydroxy-2'-deoxyguanosine (8-OHdG), which can reflect oxidative DNA damage. Persistent DNA damage may contribute to aging, carcinogenesis, and degenerative disease.

3. Antioxidant Defense Systems

Cells possess multiple layers of antioxidant protection. These include enzymatic antioxidants, non-enzymatic antioxidants, DNA repair systems, protein quality-control mechanisms, and removal of damaged cellular components.

Superoxide Dismutase

Superoxide dismutases catalyze the conversion of superoxide into hydrogen peroxide and oxygen. Mammalian cells contain different SOD isoforms located in specific cellular compartments. SOD activity therefore represents an important component of cellular defense against excessive superoxide.

Catalase

Catalase converts hydrogen peroxide into water and oxygen. It is particularly abundant in peroxisomes and protects cells from hydrogen peroxide accumulation.

Glutathione System

Glutathione is a major intracellular thiol antioxidant. The reduced form, GSH, participates in detoxification of hydrogen peroxide and lipid peroxides through glutathione peroxidases. Glutathione reductase regenerates GSH from oxidized glutathione, allowing continued antioxidant activity.

The ratio between reduced and oxidized glutathione is frequently used as an indicator of cellular redox status.

Peroxiredoxins and Thioredoxin

Peroxiredoxins are highly reactive peroxide-removing enzymes that also participate in redox signaling. Together with thioredoxin and thioredoxin reductase, they regulate protein thiol oxidation and hydrogen peroxide levels.

The antioxidant system is therefore not simply a collection of free-radical scavengers. Endogenous antioxidant enzymes and their substrates play central roles in maintaining controlled redox signaling.

4. Molecular Signaling Pathways Regulated by Oxidative Stress

NRF2–KEAP1 Pathway

Nuclear factor erythroid 2-related factor 2 (NRF2) is one of the most important regulators of cellular antioxidant defense. Under basal conditions, NRF2 is regulated by Kelch-like ECH-associated protein 1 (KEAP1), which facilitates NRF2 degradation.

Oxidative or electrophilic stress can modify sensitive cysteine residues within KEAP1, reducing NRF2 degradation. Stabilized NRF2 accumulates and enters the nucleus, where it interacts with antioxidant response elements (AREs) and promotes expression of numerous cytoprotective genes.

NRF2 regulates genes involved in glutathione synthesis, detoxification, antioxidant defense, NADPH generation, and cellular stress responses. Important targets include HMOX1, NQO1, GCLC, GCLM, GSTs, and several glutathione-related enzymes.

NRF2 activation is therefore an attractive therapeutic strategy. However, NRF2 has context-dependent effects, and persistent NRF2 activation can sometimes support survival of malignant cells. Consequently, therapeutic manipulation requires disease-specific consideration rather than nonspecific activation.

NF-κB Signaling

Oxidative stress can activate NF-κB, an important transcription factor controlling inflammatory gene expression. ROS-mediated signaling can promote degradation or modification of inhibitory proteins associated with NF-κB, allowing NF-κB to translocate into the nucleus.

Activated NF-κB promotes expression of cytokines, chemokines, adhesion molecules, and other inflammatory mediators. This creates a feedback loop in which inflammation increases ROS production and ROS further promotes inflammatory signaling. Oxidative stress and chronic inflammation can therefore reinforce one another and contribute to chronic disease.

MAPK Signaling

Mitogen-activated protein kinases, including ERK, JNK, and p38, can respond to oxidative stimuli. Moderate ROS levels may promote adaptive signaling, whereas sustained or severe oxidative stress can activate pathways associated with inflammation, apoptosis, and cellular injury.

p53 and Cell Death

Oxidative DNA damage can activate p53, which regulates cell-cycle arrest, DNA repair, senescence, and apoptosis. When damage is extensive, p53-dependent pathways can promote elimination of severely damaged cells.

This mechanism is protective under many circumstances, but excessive activation can contribute to tissue degeneration.

5. Oxidative Stress in Human Diseases

Cardiovascular Disease

Oxidative stress contributes to endothelial dysfunction, vascular inflammation, lipid oxidation, and atherosclerosis. ROS can reduce nitric oxide bioavailability and promote vascular dysfunction. Oxidized low-density lipoprotein can contribute to inflammatory responses and atherosclerotic plaque development.

Mitochondrial dysfunction and NADPH oxidase activation can increase vascular ROS production. Oxidative stress can also influence vascular smooth muscle cells and macrophages, contributing to plaque progression.

Thus, oxidative stress is closely associated with the molecular processes underlying cardiovascular disease.

Diabetes Mellitus

Hyperglycemia can increase ROS generation through mitochondrial dysfunction, advanced glycation end products, protein kinase C signaling, and altered metabolic pathways. Excess ROS can further impair insulin signaling and pancreatic β-cell function.

Because pancreatic β-cells have relatively limited antioxidant capacity, they may be particularly vulnerable to oxidative damage. Chronic oxidative stress can therefore contribute to insulin resistance and progressive β-cell dysfunction.

Oxidative stress biomarkers have been investigated as potential indicators of disease severity and complications in patients with type 2 diabetes.

Neurodegenerative Diseases

The brain is highly vulnerable to oxidative damage because of its high oxygen consumption, abundance of polyunsaturated fatty acids, and relatively limited antioxidant defenses in certain regions.

Oxidative stress has been implicated in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and other neurodegenerative conditions. Mitochondrial dysfunction, neuroinflammation, protein misfolding, and impaired antioxidant defense may interact to promote neuronal injury.

Oxidative stress may therefore function both as a contributor to disease initiation and as a mechanism that accelerates disease progression.

Cancer

ROS have a complex relationship with cancer. Moderate increases in ROS can promote cellular proliferation, survival signaling, angiogenesis, and genetic instability. Excessive ROS, however, can induce cancer-cell death.

Oxidative stress can activate NF-κB, AP-1, HIF-1α, p53, and other transcriptional pathways involved in cancer development and progression. Persistent oxidative stress can also damage DNA and contribute to mutations.

Interestingly, cancer cells often develop enhanced antioxidant capacity to survive their increased metabolic and oxidative burden. This creates opportunities for therapeutic approaches that selectively increase oxidative stress in cancer cells or inhibit their antioxidant defenses.

Chronic Inflammatory Diseases

Oxidative stress and inflammation form a bidirectional relationship. Activated immune cells generate ROS as part of antimicrobial defense, but chronic activation can result in excessive tissue exposure to reactive species.

Persistent oxidative stress can stimulate inflammatory transcription factors, while inflammatory mediators can stimulate additional ROS production. This feedback mechanism has been implicated in chronic pulmonary, gastrointestinal, cardiovascular, metabolic, and autoimmune disorders.

6. Biomarkers of Oxidative Stress

The assessment of oxidative stress is challenging because reactive species are often short-lived and highly compartmentalized. For this reason, indirect markers are frequently used.

Commonly investigated biomarkers include:

• Malondialdehyde (MDA)
• 4-hydroxynonenal (4-HNE)
• F2-isoprostanes
• 8-hydroxy-2'-deoxyguanosine (8-OHdG)
• Protein carbonyls
• Oxidized glutathione (GSSG)
• GSH/GSSG ratio
• Total antioxidant capacity
• SOD activity
• Catalase activity
• Glutathione peroxidase activity

F2-isoprostanes are considered useful markers of lipid peroxidation, whereas 8-OHdG is frequently used to assess oxidative DNA damage.

However, no single biomarker can adequately represent the complete redox state of a human organism. Biomarker interpretation should consider biological variability, sample type, disease stage, medication use, diet, lifestyle, and analytical methodology.

Recent systematic reviews indicate that oxidative-stress-related biomarkers may have clinical value in selected conditions, although standardization remains necessary before widespread clinical application.

Study Design

This article was designed as a narrative review of published scientific literature concerning oxidative stress, reactive species, molecular signaling, human disease mechanisms, biomarkers, and therapeutic interventions.

Literature Search Strategy

Scientific literature was identified through searches of major biomedical databases and scholarly sources, including PubMed/MEDLINE and publicly available peer-reviewed scientific literature.

Search terms included combinations of the following keywords:

“oxidative stress,” “reactive oxygen species,” “reactive nitrogen species,” “redox signaling,” “mitochondrial ROS,” “NRF2,” “KEAP1,” “NF-κB,” “antioxidants,” “oxidative damage,” “biomarkers,” “cancer,” “diabetes,” “cardiovascular disease,” and “neurodegenerative disease.”

Priority was given to peer-reviewed review articles, mechanistic studies, systematic reviews, and recent literature. Foundational publications were also included when they were important for understanding the development of oxidative-stress concepts.

Inclusion Criteria

Studies and reviews were considered relevant when they:

1. Investigated oxidative stress or redox biology;
2. Described molecular mechanisms of ROS/RNS generation or detoxification;
3. Examined oxidative stress in human disease;
4. Discussed antioxidant defense systems or redox-sensitive signaling pathways;
5. Investigated oxidative-stress biomarkers; or
6. Evaluated potential therapeutic strategies targeting oxidative stress.

Exclusion Criteria

Articles unrelated to human disease, oxidative stress, redox biology, antioxidant mechanisms, or therapeutic applications were excluded from the main synthesis. Non-peer-reviewed material and publications lacking sufficient methodological information were also given lower priority.

Data Synthesis

Information extracted from the literature was organized into four principal themes: molecular mechanisms, disease associations, biomarkers, and therapeutic approaches. Evidence was synthesized qualitatively to identify consistent mechanisms, emerging concepts, therapeutic opportunities, and current limitations.

8. Results

The literature reviewed demonstrates that oxidative stress is not a single molecular event but a complex disturbance involving multiple reactive species, cellular sources, antioxidant systems, and redox-sensitive signaling pathways.

Several consistent findings emerged from the literature.

First, mitochondria and NADPH oxidases are important sources of regulated and pathological ROS production. However, ROS also participate in normal signaling, demonstrating that complete elimination of ROS is neither biologically possible nor therapeutically desirable.

Second, oxidative stress can damage proteins, lipids, DNA, and cellular organelles. These molecular changes can activate inflammatory, apoptotic, metabolic, and stress-response pathways.

Third, NRF2 is a major regulator of endogenous antioxidant and cytoprotective responses. Activation of the NRF2 pathway can increase cellular capacity to neutralize reactive species and repair oxidative damage.

Fourth, oxidative stress is closely linked to inflammation. ROS can activate NF-κB and related inflammatory pathways, while inflammatory cells can produce additional ROS, creating a self-reinforcing cycle.

Fifth, conventional antioxidant supplementation has produced inconsistent clinical results. Current evidence suggests that successful therapy may require targeting the specific source, compartment, timing, and molecular consequences of oxidative stress rather than relying solely on nonspecific free-radical scavenging.

Finally, emerging therapeutic approaches include NRF2 modulation, mitochondrial-targeted antioxidants, modulation of ROS-producing enzymes, enhancement of endogenous antioxidant systems, phytochemical interventions, and disease-specific redox therapies.

9. Therapeutic Perspectives

Conventional Antioxidants

Vitamins C and E, carotenoids, polyphenols, and other dietary antioxidants have been extensively studied. Their ability to interact with reactive species provides a biological rationale for their use.

However, antioxidant supplementation has not consistently produced clinical benefits. One reason is that physiological ROS are important signaling molecules, and nonspecific scavenging may interfere with beneficial biological processes. Furthermore, many antioxidants may not reach the relevant intracellular compartment at therapeutically effective concentrations.

NRF2-Targeted Therapy

Enhancing endogenous antioxidant defenses through NRF2 activation represents a promising strategy. Rather than attempting to neutralize every reactive molecule directly, NRF2-based approaches can increase expression of multiple endogenous protective systems.

Several pharmacological and dietary compounds can influence NRF2 signaling. Nevertheless, excessive or prolonged NRF2 activation may have undesirable effects in particular disease settings, including some cancers. Therefore, selective and context-dependent NRF2 modulation remains an important research objective.

Mitochondria-Targeted Antioxidants

Because mitochondria are major sources and targets of oxidative stress, antioxidants designed to accumulate within mitochondria have received significant attention.

Mitochondria-targeted strategies aim to reduce oxidative damage at its relevant site rather than distributing antioxidant compounds nonspecifically throughout the body.

Phytochemicals and Nutraceuticals

Natural compounds such as curcumin, quercetin, resveratrol, epigallocatechin gallate, apigenin, and sulforaphane have been investigated for their antioxidant and anti-inflammatory properties. Many of these compounds influence signaling pathways rather than functioning simply as direct ROS scavengers.

In particular, several phytochemicals have been shown in experimental models to modulate NRF2/ARE signaling and other cellular defense pathways.

However, limitations such as poor bioavailability, rapid metabolism, variable preparation, and inconsistent dosing must be addressed before many nutraceutical approaches can be translated into standardized clinical treatments.

Targeting ROS-Producing Enzymes

Another strategy is to inhibit excessive production of reactive species. Potential targets include specific NADPH oxidase isoforms, xanthine oxidase, uncoupled nitric oxide synthase, and other disease-specific ROS-producing enzymes.

Such approaches may have an advantage over broad antioxidant supplementation because they can theoretically reduce pathological ROS while preserving physiological redox signaling.

Pro-Oxidant Therapeutic Strategies

Oxidative stress can also be therapeutically exploited. Cancer cells, for example, may already operate under increased oxidative pressure and depend on antioxidant systems for survival. Increasing ROS beyond the cellular tolerance threshold or inhibiting cancer-cell antioxidant defenses may therefore promote selective tumor-cell death.

This concept demonstrates the dual nature of redox biology: reducing oxidative stress may be beneficial in some diseases, whereas increasing oxidative stress may be therapeutically useful in others.

The evidence reviewed indicates that oxidative stress is a central component of multiple disease processes, but its role is more complex than a simple imbalance between “harmful ROS” and “protective antioxidants.” Reactive species are essential signaling molecules involved in cellular adaptation, immune defense, proliferation, metabolism, and programmed cell death. Therefore, therapeutic strategies that indiscriminately eliminate ROS may interfere with normal physiology.

The contemporary concept of redox homeostasis emphasizes the importance of maintaining reactive species within an appropriate biological range. Physiological ROS signaling can be described as beneficial redox signaling, whereas excessive or poorly controlled oxidation can produce molecular injury.

This distinction is particularly important for therapeutic development. Earlier approaches frequently relied on high doses of antioxidant vitamins or other radical scavengers. However, clinical outcomes have often been disappointing. The limited effectiveness of such interventions may result from poor tissue distribution, inadequate concentrations, inappropriate timing, or the failure to address the underlying source of oxidative stress.

The NRF2 pathway represents a more sophisticated therapeutic target because it regulates endogenous antioxidant and cytoprotective mechanisms. Nevertheless, NRF2 is not universally beneficial. Its activation can promote cellular survival, which may be protective in normal tissues but potentially advantageous to malignant cells under certain conditions. Current research therefore needs to focus on selective NRF2 modulation rather than indiscriminate activation.

The relationship between oxidative stress and inflammation is another important consideration. ROS can activate NF-κB and other inflammatory pathways, while inflammatory cells generate ROS. This creates a positive feedback mechanism that may maintain chronic inflammation. Interrupting this cycle may therefore provide greater therapeutic benefit than simply scavenging ROS.

Biomarker development is also critical. Current markers such as MDA, 8-OHdG, protein carbonyls, and antioxidant enzyme activities provide useful information but may not accurately reflect the spatial and temporal complexity of redox biology. Future research should prioritize highly specific, sensitive, and compartment-specific biomarkers.

Technological progress in real-time imaging, redox proteomics, metabolomics, and molecular biosensors may improve understanding of specific reactive species and their targets. Precise measurement of hydrogen peroxide, superoxide, lipid peroxides, and redox-sensitive proteins may ultimately enable individualized redox medicine.

Another important consideration is the difference between experimental and clinical evidence. Many antioxidant compounds demonstrate strong effects in cell culture and animal models, yet these effects do not necessarily translate to patients. Future clinical studies should carefully define the disease stage, oxidative pathway being targeted, appropriate dose, treatment duration, and relevant biomarker.

Overall, the future of oxidative-stress therapy is likely to move away from generalized antioxidant supplementation toward targeted manipulation of specific redox pathways.

1. Sies H, Jones DP. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nature Reviews Molecular Cell Biology. 2020;21:363–383. doi:10.1038/s41580-020-0230-3.
2. Sies H, Belousov VV, Chandel NS, et al. Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology. Nature Reviews Molecular Cell Biology. 2022;23:499–515. doi:10.1038/s41580-022-00456-z.
3. Forman HJ, Zhang H. Targeting oxidative stress in disease: promise and limitations of antioxidant therapy. Nature Reviews Drug Discovery. 2021;20:689–709. doi:10.1038/s41573-021-00233-1.
4. Halliwell B. Understanding mechanisms of antioxidant action in health and disease. Nature Reviews Molecular Cell Biology. 2024;25:13–33. doi:10.1038/s41580-023-00645-4.
5. Sies H, Mailloux RJ, Jakob U. Fundamentals of redox regulation in biology. Nature Reviews Molecular Cell Biology. 2024;25:701–719. doi:10.1038/s41580-024-00730-2.
6. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408:239–247. doi:10.1038/35041687.
7. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: How are they linked? Free Radical Biology and Medicine. 2010;49:1603–1616. doi:10.1016/j.freeradbiomed.2010.09.006.
8. Hybertson BM, Gao B, Bose SK, McCord JM. Oxidative stress in health and disease: The therapeutic potential of Nrf2 activation. Molecular Aspects of Medicine. 2011;32:234–246. doi:10.1016/j.mam.2011.10.006.
9. Liguori I, Russo G, Curcio F, et al. Oxidative stress, aging and diseases. Clinical Interventions in Aging. 2018;13:757–772. doi:10.2147/CIA.S158513.
10. Pisoschi AM, Pop A. The role of antioxidants in the chemistry of oxidative stress: A review. European Journal of Medicinal Chemistry. 2015;97:55–74. doi:10.1016/j.ejmech.2015.04.040.
11. Sies H. Oxidative stress: Introductory remarks. In: Sies H, ed. Oxidative Stress. London: Academic Press; 1985.
12. Sabitha S, Hegde SV, Agarwal SV, et al. Biomarkers of oxidative stress and their clinical relevance in type 2 diabetes mellitus patients: A systematic review. Cureus. 2024;16(8):e66570. doi:10.7759/cureus.66570.
13. Tratenšek A, Locatelli I, Grabnar I, Drobne D, Vovk T. Oxidative stress-related biomarkers as promising indicators of inflammatory bowel disease activity: A systematic review and meta-analysis. Redox Biology. 2024;77:103380. doi:10.1016/j.redox.2024.103380.
14. Mu B, Zeng Y, Luo L, Wang K. Oxidative stress-mediated protein sulfenylation in human diseases: Past, present, and future. Redox Biology. 2024;76:103332. doi:10.1016/j.redox.2024.103332.
15. Forman HJ, Davies KJA, Ursini F. How do nutritional antioxidants really work: Nucleophilic tone and para-hormesis versus free radical scavenging in the role of antioxidants in health and disease. Free Radical Biology and Medicine. 2014;66:24–35. doi:10.1016/j.freeradbiomed.2013.05.045.
16. Reczek CR, Chandel NS. ROS-dependent signal transduction. Current Opinion in Cell Biology. 2015;33:8–13. doi:10.1016/j.ceb.2014.09.010.
17. Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O. Oxidative stress and antioxidant defense. World Allergy Organization Journal. 2012;5:9–19. doi:10.1097/WOX.0b013e3182439613.
18. Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nature Reviews Drug Discovery. 2013;12:931–947. doi:10.1038/nrd4002.
19. Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Current Biology. 2014;24:R453–R462. doi:10.1016/j.cub.2014.03.034.
20. DeNicola GM, Karreth FA, Humpton TJ, et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature. 2011;475:106–109. doi:10.1038/nature10189.